Soliris (Eculizumab) 300 mg/30 mL (10mg/mL)
Known name: Soliris (Eculizumab)
Eculizumab (Soliris) is indicated for the following diseases in adults and children.
Paroxysmal nocturnal hemoglabinuria (PNH).
Evidence of clinical benefit has been shown independently of the history of transfusion in patients with high disease activity with clinical symptoms and hemolysis.
Atypical hemolytic uremic syndrome (aHUS)
Soliris (Eculizumab) 300 mg/30 mL (10mg/mL) You can contact us to find out the price:Contact for detailed information